Abnormal elevation of myocardial necrosis biomarkers after coronary artery bypass grafting without established myocardial infarction assessed by cardiac magnetic resonance

• Published in: Journal of cardiothoracic surgery 2017-12, Vol.12 (1), p.122-122, Article 122
• Main Authors: Oikawa, Fernando Teiichi Costa, Hueb, Whady, Nomura, Cesar Higa, Hueb, Alexandre Ciappina, Villa, Alexandre Volney, da Costa, Leandro Menezes Alves, de Melo, Rodrigo Morel Vieira, Rezende, Paulo Cury, Segre, Carlos Alexandre Wainrober, Garzillo, Cibele Larrosa, Lima, Eduardo Gomes, Ramires, Jose Antonio Franchini, Filho, Roberto Kalil
• Format: Article
• Language: English
• Subjects: Biological markers; Biomarkers; Cardiac patients; Coronary artery bypass; Coronary bypass surgery; Creatine; Creatine kinase; Diagnosis; Electrocardiography; Heart attack; Medical research; Myocardial infarction; Necrosis; Periprocedural; Product enhancement; Rare earth metal compounds; Surgery; Troponin
• ISSN: 1749-8090; 1749-8090
• DOI: 10.1186/s13019-017-0684-3

The diagnosis of peri-procedural myocardial infarction is complex, especially after the emergence of high-sensitivity markers of myocardial necrosis. In this study, patients with normal baseline cardiac biomarkers and formal indication for elective on-pump coronary bypass surgery were evaluated. Electrocardiograms, cardiac biomarkers, and cardiac magnetic resonance imaging with late gadolinium enhancement were performed before and after procedures. Myocardial infarction was defined as more than ten times the upper reference limit of the 99th percentile for troponin I and for creatine kinase isoform (CK-MB) and by the findings of new late gadolinium enhancement on cardiac magnetic resonance. We assessed the release of cardiac biomarkers in patients with no evidence of myocardial infarction on cardiac magnetic resonance. Of 75 patients referred for on-pump coronary bypass surgery, 54 (100%) did not have evidence of myocardial infarction on cardiac magnetic resonance. However, all had a peak troponin I above the 99th percentile; 52 (96%) had an elevation 10 times higher than the 99th percentile. Regarding CK-MB, 54 (100%) patients had a peak CK-MB above the 99th percentile limit, and only 13 (24%) had an elevation greater than 10 times the 99th percentile. The median value of troponin I peak was 3.15 (1.2 to 3.9) ng/mL, which represented 78.7 times the 99th percentile. In this study, different from CK-MB findings, troponin was significantly increased in the absence of myocardial infarction on cardiac magnetic resonance. Thus, CK-MB was more accurate than troponin I for excluding procedure-related myocardial infarction. These data suggest a higher troponin cutoff for the diagnosis of coronary bypass surgery related myocardial infarction. http://www.isrctn.com/ISRCTN09454308 . Registered 08 May 2012.